SMIFS Capital Markets Intrinsic Value
NEXOME Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹81.60 | ₹65.28 - ₹97.92 | +2.9% | EPS: ₹6.80, Sector P/E: 12x |
| Book Value Method | asset | ₹198.28 | ₹178.45 - ₹218.11 | +150.0% | Book Value/Share: ₹256.67, P/B: 0.8x |
| Revenue Multiple Method | revenue | ₹60.00 | ₹54.00 - ₹66.00 | -24.3% | Revenue/Share: ₹60.00, P/S: 1.0x |
| EBITDA Multiple Method | earnings | ₹66.67 | ₹60.00 - ₹73.34 | -15.9% | EBITDA: ₹8.00Cr, EV/EBITDA: 5x |
| PEG Ratio Method | growth | ₹43.52 | ₹39.17 - ₹47.87 | -45.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹56.03 | ₹50.43 - ₹61.63 | -29.4% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹198.17 | ₹178.35 - ₹217.99 | +149.9% | EPS: ₹6.80, BVPS: ₹256.67 |
Want to compare with current market value? Check NEXOME share price latest .
Valuation Comparison Chart
NEXOME Intrinsic Value Analysis
What is the intrinsic value of NEXOME?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of SMIFS Capital Markets (NEXOME) is ₹66.67 (median value). With the current market price of ₹79.31, this represents a -15.9% variance from our estimated fair value.
The valuation range spans from ₹43.52 to ₹198.28, indicating ₹43.52 - ₹198.28.
Is NEXOME undervalued or overvalued?
Based on our multi-method analysis, SMIFS Capital Markets (NEXOME) appears to be trading above median value by approximately 15.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.43 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 2.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.22x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for SMIFS Capital Markets
Additional stock information and data for NEXOME
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-6 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-4 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹46 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |